Sep 27 |
Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?
|
Sep 16 |
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
|
Sep 16 |
Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
|
Sep 11 |
Are Medical Stocks Lagging Adagene (ADAG) This Year?
|
Aug 29 |
Adagene to Participate in Investor Conferences in September
|
Aug 26 |
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
|
Aug 9 |
Is MannKind (MNKD) Stock Outpacing Its Medical Peers This Year?
|
Jul 28 |
Adagene First Half 2024 Earnings: US$0.39 loss per share (vs US$0.094 loss in 1H 2023)
|
Jul 25 |
Adagene ADR GAAP EPS of -$0.31
|
Jul 25 |
Adagene Reports Six Month Financial Results for 2024 and Provides Corporate Update
|